138O CNS metastases in HER2-positive metastatic breast cancer treated with trastuzumab deruxtecan: DESTINY-Breast01 subgroup analyses
Guy Jérusalem, Y.H. Park, Toshinari Yamashita, Sara A. Hurvitz, S. Chen, Jillian Cathcart, C. Lee, Christophe Perrin
Topics & Concepts
MedicineInternal medicineTrastuzumabMetastatic breast cancerBreast cancerOncologyPopulationGastroenterologyCancerEnvironmental healthCancer Treatment and PharmacologyBrain Metastases and TreatmentRadiopharmaceutical Chemistry and Applications